MedTrace Logo

Evaluation of WIRION™ EPS in Lower Extremities Arteries

NCT02780349 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2018-03-15

Study results available
· View outcomes & findings →

Summary

Demonstrate the safety and performance of the WIRION™ EPS in subjects undergoing lower extremity atherectomy for the treatment of Peripheral Arterial Disease (PAD)

Conditions

  • Peripheral Arterial Disease (PAD)

Interventions

DEVICE

WIRION

Embolic Protection System

Sponsors & Collaborators

  • Gardia Medical

    lead INDUSTRY

Principal Investigators

  • William Gray, MD · Main Line Health

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-08-30
Completion
2017-09-30

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02780349 on ClinicalTrials.gov